Fig. 1From: Patient-reported outcomes in patients with cystic fibrosis with a G551D mutation on ivacaftor treatment: results from a cross-sectional studyCFQ-R results by domain. The LS mean (SE) CFQ-R score for each domain is shown. *P < 0.05, †P < 0.01, ‡P < 0.001 for the difference between G551D/IVA and F508del/SOC groups. a 6–11-year and ≥14-year versions only. b ≥14-year version only. c 6–11-year version only. d12–13-year and ≥14-year versions only. CFQ-R Cystic Fibrosis Questionnaire-Revised, IVA ivacaftor, LS least squares, SE standard error, SOC standard of careBack to article page